In line with the understanding that the receptor for IL-22 (which is comprised of the receptor dimer IL22RA1 and IL10RB) is expressed in keratinocytes, these cells exhibited pronounced hyperactivation, surpassing even the levels observed in untreated AD. This evidence concerns the gene IL22RA1 and Alzheimer disease.